Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1066 AL 1080

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2016 Nov 25;16(1):195. doi: 10.1186/s12877-016-0371-6.

African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation

Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.

Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.

Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results

Lee KJ, Cho SJ, Kim BC, Park M, Lee JH.

Adv Ther. 2017 Feb;34(2):481-494. doi: 10.1007/s12325-016-0465-8. Epub 2016 Dec 20.

The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective

Salehi A, Ashford JW, Mufson EJ.

Curr Alzheimer Res. 2016;13(1):2-6. doi: 10.2174/1567205012999151021102914.

Atorvastatin May Correct Dyslipidemia in Adult Patients at Risk for Alzheimer's Disease Through an Anti-Inflammatory Pathway

Zhao L, Zhao Q, Zhou Y, Zhao Y, Wan Q.

CNS Neurol Disord Drug Targets. 2016;15(1):80-5. doi: 10.2174/1871527315999160111160143.

Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis

Rai V.

Mol Neurobiol. 2017 Mar;54(2):1173-1186. doi: 10.1007/s12035-016-9722-8. Epub 2016 Jan 28.

The Bridging Integrator 1 Gene Polymorphism rs744373 and the Risk of Alzheimer's Disease in Caucasian and Asian Populations: An Updated Meta-Analysis

Zhu R, Liu X, He Z.

Mol Neurobiol. 2017 Mar;54(2):1419-1428. doi: 10.1007/s12035-016-9760-2. Epub 2016 Feb 4.

Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis

Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, Onyike CU.

Dement Geriatr Cogn Disord. 2016;41(1-2):109-22. doi: 10.1159/000443205. Epub 2016 Feb 9.

Alzheimer's disease and diet: a systematic review

Yusufov M, Weyandt LL, Piryatinsky I.

Int J Neurosci. 2017 Feb;127(2):161-175. doi: 10.3109/00207454.2016.1155572. Epub 2016 Mar 9.

Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up

Turró-Garriga O, Garre-Olmo J, Calvó-Perxas L, Reñé-Ramírez R, Gascón-Bayarri J, Conde-Sala JL.

J Alzheimers Dis. 2016;51(2):357-66. doi: 10.3233/JAD-150706.

The Effects of Cognitive Training for Elderly: Results from My Mind Project

Giuli C, Papa R, Lattanzio F, Postacchini D.

Rejuvenation Res. 2016 Dec;19(6):485-494. doi: 10.1089/rej.2015.1791. Epub 2016 Apr 8.

Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers

Schütt T, Helboe L, Pedersen LØ, Waldemar G, Berendt M, Pedersen JT.

J Alzheimers Dis. 2016 Mar 15;52(2):433-49. doi: 10.3233/JAD-151085.

Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Y, Yin S, Zhang D.

J Alzheimers Dis. 2016 Mar 31;52(2):631-9. doi: 10.3233/JAD-151207.

Common variant in PTK2B is associated with late-onset Alzheimer's disease: A replication study and meta-analyses

Li YQ, Tan MS, Wang HF, Tan CC, Zhang W, Zheng ZJ, Kong LL, Wang ZX, Tan L, Jiang T, Tan L, Yu JT.

Neurosci Lett. 2016 May 16;621:83-87. doi: 10.1016/j.neulet.2016.04.020. Epub 2016 Apr 11.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias